Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1982 1
1983 1
1986 3
1988 3
1990 1
1992 2
1994 4
1995 10
1996 7
1997 16
1998 4
1999 15
2000 18
2001 5
2002 6
2003 6
2004 5
2005 5
2006 3
2007 4
2008 6
2009 5
2010 11
2011 13
2012 8
2013 6
2014 5
2015 3
2016 8
2017 14
2018 12
2019 10
2020 9
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

221 results
Results by year
Filters applied: . Clear all
Page 1
Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM.
Nordestgaard BG, Langlois MR, Langsted A, Chapman MJ, Aakre KM, Baum H, Borén J, Bruckert E, Catapano A, Cobbaert C, Collinson P, Descamps OS, Duff CJ, von Eckardstein A, Hammerer-Lercher A, Kamstrup PR, Kolovou G, Kronenberg F, Mora S, Pulkki K, Remaley AT, Rifai N, Ros E, Stankovic S, Stavljenic-Rukavina A, Sypniewska G, Watts GF, Wiklund O, Laitinen P; European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative. Nordestgaard BG, et al. Among authors: pulkki k. Atherosclerosis. 2020 Feb;294:46-61. doi: 10.1016/j.atherosclerosis.2019.12.005. Epub 2020 Jan 9. Atherosclerosis. 2020. PMID: 31928713 Review.
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.
Nordestgaard BG, Langsted A, Mora S, Kolovou G, Baum H, Bruckert E, Watts GF, Sypniewska G, Wiklund O, Borén J, Chapman MJ, Cobbaert C, Descamps OS, von Eckardstein A, Kamstrup PR, Pulkki K, Kronenberg F, Remaley AT, Rifai N, Ros E, Langlois M; European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) joint consensus initiative. Nordestgaard BG, et al. Among authors: pulkki k. Eur Heart J. 2016 Jul 1;37(25):1944-58. doi: 10.1093/eurheartj/ehw152. Epub 2016 Apr 26. Eur Heart J. 2016. PMID: 27122601 Free PMC article.
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM.
Langlois MR, Nordestgaard BG, Langsted A, Chapman MJ, Aakre KM, Baum H, Borén J, Bruckert E, Catapano A, Cobbaert C, Collinson P, Descamps OS, Duff CJ, von Eckardstein A, Hammerer-Lercher A, Kamstrup PR, Kolovou G, Kronenberg F, Mora S, Pulkki K, Remaley AT, Rifai N, Ros E, Stankovic S, Stavljenic-Rukavina A, Sypniewska G, Watts GF, Wiklund O, Laitinen P; European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative. Langlois MR, et al. Among authors: pulkki k. Clin Chem Lab Med. 2020 Mar 26;58(4):496-517. doi: 10.1515/cclm-2019-1253. Clin Chem Lab Med. 2020. PMID: 31855562 Free article.
Morphologic and biochemical hallmarks of apoptosis.
Saraste A, Pulkki K. Saraste A, et al. Among authors: pulkki k. Cardiovasc Res. 2000 Feb;45(3):528-37. doi: 10.1016/s0008-6363(99)00384-3. Cardiovasc Res. 2000. PMID: 10728374 Review.
Tau, S100B and NSE as Blood Biomarkers in Acute Cerebrovascular Events.
Onatsu J, Vanninen R, JÄkÄlÄ P, Mustonen P, Pulkki K, Korhonen M, Hedman M, HÖglund K, Blennow K, Zetterberg H, Herukka SK, Taina M. Onatsu J, et al. Among authors: pulkki k. In Vivo. 2020 Sep-Oct;34(5):2577-2586. doi: 10.21873/invivo.12075. In Vivo. 2020. PMID: 32871787 Free PMC article.
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM.
Langlois MR, Chapman MJ, Cobbaert C, Mora S, Remaley AT, Ros E, Watts GF, Borén J, Baum H, Bruckert E, Catapano A, Descamps OS, von Eckardstein A, Kamstrup PR, Kolovou G, Kronenberg F, Langsted A, Pulkki K, Rifai N, Sypniewska G, Wiklund O, Nordestgaard BG; European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative. Langlois MR, et al. Among authors: pulkki k. Clin Chem. 2018 Jul;64(7):1006-1033. doi: 10.1373/clinchem.2018.287037. Epub 2018 May 14. Clin Chem. 2018. PMID: 29760220 Free article.
Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial.
Bjermo H, Iggman D, Kullberg J, Dahlman I, Johansson L, Persson L, Berglund J, Pulkki K, Basu S, Uusitupa M, Rudling M, Arner P, Cederholm T, Ahlström H, Risérus U. Bjermo H, et al. Among authors: pulkki k. Am J Clin Nutr. 2012 May;95(5):1003-12. doi: 10.3945/ajcn.111.030114. Epub 2012 Apr 4. Am J Clin Nutr. 2012. PMID: 22492369 Clinical Trial.
Biomarkers of neutropenic sepsis.
Jantunen E, Juutilainen A, Hämäläinen S, Koivula I, Vänskä M, Purhonen AK, Pulkki K. Jantunen E, et al. Among authors: pulkki k. Duodecim. 2016;132(21):1946-51. Duodecim. 2016. PMID: 29190045 Review.
The usage of procalcitonin in Finland.
Tujula B, Kokki M, Pulkki K, Romppanen J, Sjövall S, Tuominen H, Kokki H. Tujula B, et al. Among authors: pulkki k. Acta Anaesthesiol Scand. 2018 Apr 19. doi: 10.1111/aas.13135. Online ahead of print. Acta Anaesthesiol Scand. 2018. PMID: 29675987
221 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page